Medicalgorithmics S.A. (WSE:MDG)

Medicalgorithmics Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.74	5.5	25.5	26.17	11.67	16.2
Cash & Short-Term Investments	2.74	5.5	25.5	26.17	11.67	16.2
Cash Growth	-74.13%	-78.42%	-2.54%	124.27%	-27.97%	45.27%
Accounts Receivable	8.07	7.47	8.41	5.48	19.24	16.16
Other Receivables	-	-	-	15.58	4.43	6.71
Receivables	8.07	7.47	8.41	21.06	23.67	22.88
Inventory	6.89	9.39	9.32	8.77	-	-
Prepaid Expenses	-	-	-	0.05	0.17	0.26
Other Current Assets	-	-	-	0.03	1.25	1.41
Total Current Assets	17.7	22.37	43.23	56.08	36.75	40.74
Property, Plant & Equipment	3.45	2.35	2.28	2	27	23.54
Long-Term Investments	0.02	0.02	0.02	0.02	0.1	0.2
Goodwill	18.97	18.97	18.97	18.97	0.77	84.37
Other Intangible Assets	56.24	51.42	47.87	44.23	46.45	109.19
Long-Term Deferred Tax Assets	-	-	-	-	-	17.16
Long-Term Deferred Charges	6.81	8.08	5.86	0.72	3.35	8.21
Other Long-Term Assets	1.72	2.6	3.4	-	-	-
Total Assets	104.91	105.81	121.63	122.02	114.41	283.4
Accounts Payable	2.74	2.42	3.14	2.25	5.78	3.45
Accrued Expenses	3.09	3.52	3.25	1.73	24.75	23.42
Short-Term Debt	-	-	-	-	0.04	0.03
Current Portion of Long-Term Debt	-	2.25	3.22	4.06	4.12	4.58
Current Portion of Leases	0.73	-	-	0.95	5.37	5.47
Current Income Taxes Payable	0.18	0.2	0.17	0.13	0.11	0.04
Current Unearned Revenue	0.57	0.43	1.88	-	-	-
Other Current Liabilities	0.13	0.15	0.63	1.16	0.09	0.17
Total Current Liabilities	7.44	8.97	12.29	10.28	40.26	37.15
Long-Term Debt	13.44	3.89	1.08	3.93	13.89	20.33
Long-Term Leases	1.32	1.6	1.39	0.32	5.02	8.98
Long-Term Unearned Revenue	4.21	5.15	5.59	4.18	-	-
Long-Term Deferred Tax Liabilities	8.69	8.93	8.57	8.29	4.38	5.33
Other Long-Term Liabilities	0	0.09	0.15	0.15	3.37	4.25
Total Liabilities	35.2	28.63	29.07	27.34	67.02	76.04
Common Stock	1	1	1	1	0.5	0.43
Additional Paid-In Capital	-	210.98	210.98	210.98	148.12	137.13
Retained Earnings	-140.15	-133.46	-117.38	-116.8	-104.76	75.88
Comprehensive Income & Other	208.85	-1.35	-2.04	-0.5	3.52	-6.09
Total Common Equity	69.7	77.17	92.56	94.67	47.39	207.36
Minority Interest	0.01	0.01	0.01	0.01	0.01	0.01
Shareholders' Equity	69.71	77.19	92.57	94.68	47.39	207.37
Total Liabilities & Equity	104.91	105.81	121.63	122.02	114.41	283.4
Total Debt	15.5	7.73	5.69	9.26	28.43	39.38
Net Cash (Debt)	-12.76	-2.23	19.81	16.91	-16.77	-23.19
Net Cash Growth	-	-	17.20%	-	-	-
Net Cash Per Share	-1.28	-0.22	1.99	2.97	-3.69	-5.60
Filing Date Shares Outstanding	9.95	9.95	9.95	9.95	4.98	4.33
Total Common Shares Outstanding	9.95	9.95	9.95	9.95	4.98	4.33
Working Capital	10.26	13.4	30.93	45.79	-3.51	3.6
Book Value Per Share	7.00	7.75	9.30	9.51	9.52	47.91
Tangible Book Value	-5.51	6.78	25.72	31.48	0.17	13.8
Tangible Book Value Per Share	-0.55	0.68	2.58	3.16	0.03	3.19
Buildings	-	-	-	-	2.23	2.44
Machinery	5.33	4.47	4.46	3.98	38.99	27.45
Leasehold Improvements	0.65	0.65	0.65	0.65	0.65	0.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.